SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Don't Floss, You Lose - (ATRX) To the RESCUE.
ATRX 0.00010000.0%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Fred McCutcheon who wrote (164)7/6/2000 5:02:04 PM
From: Fred McCutcheon  Read Replies (1) of 182
 
Atrix Receives Canadian Marketing Approval for
ATRIDOX(R)

FORT COLLINS, Colo., July 6 /PRNewswire/ -- Atrix Laboratories (Nasdaq: ATRX - news) announced today that ATRIDOX®, an innovative pharmaceutical treatment for adult periodontal disease, has been approved for marketing in Canada. Block Drug Company, Inc. (Nasdaq: BLOCA - news) will market the product in Canada for Atrix Laboratories, through Block's Canadian subsidiary. In addition to receiving royalties on sales, Atrix will receive manufacturing margins for the production of ATRIDOX.

biz.yahoo.com

Fred McCutcheon
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext